SIRPA and neoplasm: Studies in syngeneic mouse models suggest that anti-SIRPα antibody modifies the tumor microenvironment with an enhancement in the M1/M2 macrophage ratio.44 48 Tumor-associated macrophages can be divided into M1 and M2 phenotypes, which are thought to have anti-tumorigenic and pro-tumorigenic activities, respectively.